EyePoint Pharmaceuticals, Inc. is in its Venus mahadasha (21 Jan 2008 to 21 Jan 2028), Mercury antardasha (21 Jan 2024 to 21 Nov 2026) and Saturn pratyantar (10 Jun 2026 to 21 Nov 2026).
Next: pratyantar Ketu from 21 Nov 2026; antardasha Ketu from 21 Nov 2026; mahadasha Sun from 21 Jan 2028.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Makara (Capricorn) | 13°51′ | 11th | Shravana 2 |
| Moon | Simha (Leo) | 7°39′ | 6th | Magha 3 |
| Mars | Vrishchika (Scorpio) | 28°56′ | 9th | Jyeshtha 4 |
| Mercury | Makara (Capricorn) | 1°54′ | 11th | Uttara Ashadha 2 |
| Jupiter | Kanya (Virgo) | 24°54′ | 7th | Chitra 1 |
| Venus | Dhanu (Sagittarius) | 28°31′ | 10th | Uttara Ashadha 1 |
| Saturn (R) | Mithuna (Gemini) | 28°52′ | 4th | Punarvasu 3 |
| Rahu | Mesha (Aries) | 3°00′ | 2nd | Ashwini 1 |
| Ketu | Tula (Libra) | 3°00′ | 8th | Chitra 3 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how EYPT moved in each period against the S&P 500, transits, fundamentals and news.